<!DOCTYPE HTML>
<html>
  <head>
    <meta http-equiv="Content-type" content="text/html;" >
	<title>Morphine CR</title>
	</head>
  <body onLoad="init();">
    <div data-role="page" data-theme="b">
  	<div data-role="header" data-theme="b" data-position="fixed">
    	<h1>Morphine CR</h1> 
    	<a href="#" data-rel="back" data-icon="arrow-l" data-theme="b" data-direction="reverse" >Back</a>
	</div>
    <div data-role="content">

			<h3>Brand names: Morphine Controlled Release (CR),Sustained Release (SR), (MS Contin, Oramorph SR); Extended Release (ER) (Avinza, Kadian)</h3>
<hr>
					<h3>Adult Starting Dose (Max Per Day)</h3>	
					<ul>
						<li>Initial dose = 15mg q8-12 hours (CR/ SR) </li>
						<li>Initial dose = 30mg Q24h (ER) </li>
						<li>Titration: total daily increments of &lt; 30-40mg/ day may be made Q 2 days</li>
						<li>Avinza = maximum of 1600mg per day</li>
					</ul>
<hr>
					<h3>Advantages</h3>	
					<ul>
						<li>Preferred first-line longacting agent because of similar efficacy to other long-acting Opioids, comparable safety profile, provider familiarity with its use and lower cost </li>
						<li>Controlledrelease tablets should be swallowed whole, not broken, chewed, or crushed</li>
						<li>For patients who have difficulty swallowing, SR and ER capsules may be opened and the pellets may be sprinkled onto a small amount of soft food (such as apple sauce); The mixture should be taken within 30 minutes of sprinkling. The pellets must not be chewed or crushed, and the mouth should be rinsed to ensure that all pellets have been swallowed</li> 
						<li>Avinza: 24- hour extended release capsules</li> 
								 			</ul> 
<hr>
					<h3>Disadvantages</h3>	
					<ul>
						<li>Contraindications include respiratory depression in the absence of resuscitative equipment, acute or severe bronchial asthma or hypercarbia and known or suspected paralytic ileus</li> 
					</ul>
<hr>
					<h3>Pregnancy Category</h3>	
					<ul>
							<li>Risk cannot be ruled out, but potential benefits may justify potential risk</li>	
					</ul>
<hr>
					<h3>Safety Margin</h3>	
					<ul>
						<li>Serious potential for overdose in the Opioid novice, use with caution and with gradual dose increase. Start with the lowest dose possible </li>
						<li>All Opioids are contraindicated in patients who have received MAOIs within 14 days </li>
						<li>Morphine has active metabolites (M3G and M6G) which may accumulate in renal impairment and contribute to toxic effects</li> 
						<li>Use extreme caution using Opioids in patients with conditions accompanied by hypoxia, hypercapnia, or decreased respiratory reserve </li>
						<li>Avinza: due to fumaric acid content, doses above 1600 mg may result in serious renal toxicity</li> 					
					</ul>
<hr>
					<h3>Efficacy</h3>	
					<ul>
						<li>Long acting Opioids are effective for continuous, chronic pain </li>
						<li>Opioids are highly effective in pain management </li>
						<li>Methadone is FDA approved for the detoxification treatment of Opioid addiction; If used in detoxification, then it must be used as part of an FDA approved program</li>		
					</ul>



    </div><!-- end jqm content -->
   
    </div><!-- end jqm page -->
  </body>
</html>
